| 2023 | | A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study to Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19 | 허중연 |
| 2021 | | A standardized analytics pipeline for reliable and rapid development and validation of prediction models using observational health data | 박래웅 |
| 2020 | | Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports (Diabetes Metab J 2020;44:349-53) | 전자영 |
| 2021 | | Adamantiades-Behçet's disease (Behçet's disease) and COVID-19 | 이은소 |
| 2020 | | Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study | 유슬기 |
| 2023 | | Antibody response in patients undergoing chronic hemodialysis post-severe acute respiratory syndrome coronavirus 2 vaccination: A prospective observational study | 김경민, 김흥수, 박범희, 박인휘, 신규태, 신호준, 이민정, 이윤지 |
| 2022 | | Antimicrobial effects of microwave plasma-activated water with skin protective effect for novel disinfectants in pandemic era | 김철호 |
| 2023 | | Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against broad-spectrum neutralizing antibodies through epitopes mapping | SHAH, MASAUD, 우현구 |
| 2022 | | Changes in the characteristics of trauma patients after the early COVID-19 outbreak A retrospective study of a regional level 1 trauma center in Republic of Korea | 강병희, 권준식, 문종환, 박지예, 정경원, 허요, 허윤정 |
| 2021 | | Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of Diagnosis | 김은진, 신승수 |
| 2021 | | Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study | 허중연 |
| 2023 | | Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials | 허중연 |
| 2022 | | Clinical findings, viral load, and outcomes of COVID-19: Comparison of patients with negative and positive initial chest computed tomography | 김은진, 신승수 |
| 2020 | | Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea | 김대중 |
| 2022 | | Comparative analysis of machine learning-based approaches for identifying therapeutic peptides targeting SARS-CoV-2 | Balachandran, Manavalan, Basith, Shaherin, 이광 |
| 2022 | | Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study | 박래웅 |
| 2024 | | Comparison of pediatric poisoning patterns before and during the COVID-19 pandemic in South Korea | 고유라, 안주호, 양희원 |
| 2021 | | COVID-19 Changes Medical Learning | 정민석 |
| 2023 | | COVID-19 Vaccine-Associated Pneumonitis in the Republic of Korea: A Nationwide Multicenter Survey | 박주헌 |
| 2020 | | COVID-19, asthma, and biological therapies: What we need to know | 박해심 |
| 2024 | | Data Resource Profile: Health Insurance Review and Assessment Service Covid-19 Observational Medical Outcomes Partnership (HIRA Covid-19 OMOP) database in South Korea | 박래웅 |
| 2021 | | Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic | 이진수, 홍지만 |
| 2020 | | Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study | 박래웅 |
| 2022 | | Does having various types of fear related to COVID-19 disrupt individuals’ daily life?: Findings from a nationwide survey in Korea | 이순영, 주영준 |
| 2024 | | ECMO is associated with decreased hospital mortality in COVID-19 ARDS | 박주헌 |
| 2021 | | Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19 | 김대중 |
| 2021 | | Effects of early corticosteroid use in patients with severe coronavirus disease 2019 | 김은진 |
| 2022 | | Forms of cholangitis to be considered after SARS-CoV-2 infection | 김순선 |
| 2020 | | Gains from the Novel Corona Virus | 정민석 |
| 2024 | | Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2021 | | Global Impact of COVID-19 on Stroke Care and IV Thrombolysis | 이진수 |
| 2022 | | Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality | 이진수 |
| 2024 | | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Harnessing SARS-CoV-2-specific CD8+ T cells to kill target tumor cells for cancer immunotherapy | 김영롱, 정근옥, 허중연 |
| 2021 | | Healthcare considerations for special populations during the COVID-19 pandemic: A review | 송주은 |
| 2023 | | Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection | 허중연 |
| 2022 | | Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study | 허중연 |
| 2023 | | Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial | 김은진, 허중연 |
| 2024 | | Impact of social distancing policy on pediatric emergency ophthalmic severity during the coronavirus disease 2019 pandemic | 김중헌, 박범희, 정승아 |
| 2024 | | Incidence of mental health diagnoses during the COVID-19 pandemic: a multinational network study | 박래웅 |
| 2022 | | Increased Healthcare Delays in Tuberculosis Patients During the First Wave of COVID-19 Pandemic in Korea: A Nationwide Cross-Sectional Study | 박광주 |
| 2022 | | Infectivity of Coronavirus Disease 2019: A Prospective Cohort Study in the Korean Metropolitan Area | 정윤정 |
| 2021 | | Information and general guidance for healthcare professionals in the fourth wave of covid-19 | 박진희 |
| 2020 | | Interim Guidelines on Antiviral Therapy for COVID-19 | 허중연 |
| 2023 | | Is COVID-19 induced reductions in the level of physical activity associated with increased depressive symptoms in patients with hypertension? | 이순영, 주영준 |
| 2023 | | Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample | 이순영, 한진아 |
| 2024 | | Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination | 현학준 |
| 2024 | | Longitudinal immune kinetics of COVID-19 booster versus primary series vaccination: Insight into the annual vaccination strategy | 허중연, 현학준 |
| 2022 | | Lung transplantation for severe COVID-19-related ARDS | 박지은 |
| 2020 | | Management of liver diseases during the pandemic of coronavirus disease-19 | 김순선 |
